A detailed history of Albion Financial Group transactions in Amgen Inc stock. As of the latest transaction made, Albion Financial Group holds 26,682 shares of AMGN stock, worth $7.03 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
26,682
Previous 26,107 2.2%
Holding current value
$7.03 Million
Previous $8.16 Million 5.39%
% of portfolio
0.6%
Previous 0.62%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$309.38 - $337.38 $177,893 - $193,993
575 Added 2.2%
26,682 $8.6 Million
Q2 2024

Jul 10, 2024

BUY
$262.75 - $319.31 $44,930 - $54,602
171 Added 0.66%
26,107 $8.16 Million
Q1 2024

Apr 19, 2024

BUY
$268.87 - $324.56 $35,221 - $42,517
131 Added 0.51%
25,936 $7.37 Million
Q4 2023

Jan 26, 2024

SELL
$255.7 - $288.46 $45,514 - $51,345
-178 Reduced 0.69%
25,805 $7.43 Million
Q3 2023

Nov 01, 2023

BUY
$218.65 - $271.46 $356,836 - $443,022
1,632 Added 6.7%
25,983 $6.98 Million
Q2 2023

Jul 25, 2023

SELL
$214.27 - $253.37 $118,705 - $140,366
-554 Reduced 2.22%
24,351 $5.41 Million
Q1 2023

Apr 18, 2023

SELL
$225.79 - $275.2 $40,416 - $49,260
-179 Reduced 0.71%
24,905 $6.02 Million
Q4 2022

Feb 03, 2023

BUY
$229.03 - $291.01 $5,496 - $6,984
24 Added 0.1%
25,084 $6.59 Million
Q3 2022

Oct 27, 2022

SELL
$224.46 - $253.15 $1,795 - $2,025
-8 Reduced 0.03%
25,060 $5.65 Million
Q2 2022

Jul 29, 2022

BUY
$230.71 - $256.74 $14,304 - $15,917
62 Added 0.25%
25,068 $6.1 Million
Q1 2022

May 09, 2022

SELL
$219.27 - $242.57 $7,235 - $8,004
-33 Reduced 0.13%
25,006 $6.05 Million
Q4 2021

Feb 15, 2022

BUY
$198.88 - $227.6 $129,669 - $148,395
652 Added 2.67%
25,039 $5.63 Million
Q3 2021

Oct 19, 2021

SELL
$212.27 - $248.7 $23,349 - $27,357
-110 Reduced 0.45%
24,387 $5.19 Million
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $490,284 - $543,934
2,099 Added 9.37%
24,497 $5.97 Million
Q4 2020

Feb 19, 2021

BUY
$216.38 - $257.67 $134,804 - $160,528
623 Added 2.86%
22,398 $5.15 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $94,563 - $105,162
403 Added 1.89%
21,775 $5.53 Million
Q2 2020

Aug 17, 2020

BUY
$197.81 - $242.74 $230,646 - $283,034
1,166 Added 5.77%
21,372 $5.04 Million
Q1 2020

May 08, 2020

BUY
$182.24 - $241.7 $132,852 - $176,199
729 Added 3.74%
20,206 $4.1 Million
Q4 2019

Jan 31, 2020

BUY
$189.21 - $243.2 $54,114 - $69,555
286 Added 1.49%
19,477 $4.7 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $19,326 - $23,156
111 Added 0.58%
19,191 $3.71 Million
Q2 2019

Aug 08, 2019

BUY
$166.7 - $195.41 $344,402 - $403,717
2,066 Added 12.14%
19,080 $3.52 Million
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $535,556 - $603,688
2,961 Added 21.07%
17,014 $3.23 Million
Q4 2018

Jan 28, 2019

BUY
$178.4 - $208.25 $239,056 - $279,055
1,340 Added 10.54%
14,053 $2.74 Million
Q3 2018

Nov 20, 2018

BUY
$185.29 - $208.89 $102,094 - $115,098
551 Added 4.53%
12,713 $2.64 Million
Q2 2018

Aug 15, 2018

BUY
$166.05 - $186.51 $493,500 - $554,307
2,972 Added 32.34%
12,162 $2.25 Million
Q1 2018

Apr 17, 2018

BUY
$169.43 - $198.0 $1.11 Million - $1.3 Million
6,575 Added 251.43%
9,190 $1.57 Million
Q4 2017

Feb 22, 2018

BUY
$168.79 - $188.59 $151,067 - $168,788
895 Added 52.03%
2,615 $455,000
Q2 2017

Aug 15, 2017

BUY
N/A
1,720
1,720 $296,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Albion Financial Group Portfolio

Follow Albion Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.